29 immune-related genes pairs signature predict the prognosis of cervical cancer patients

Author:

Nie Han,Bu Fanqin,Xu Jiasheng,Li Taoshen,Huang Jun

Abstract

AbstractTo screen the key immune genes in the development of cervical cancer, construct immune related gene pairs (IRGPs), and evaluate their influence on the prognosis of cervical cancer. Tumor Genome Atlas (TCGA) database and geo database were downloaded as training set and validation set respectively, and immune related gene data were downloaded from immport. IRGPs model is established by machine learning, and the model is analyzed and evaluated. Using the Uclcan to analyze the immune genes expression in cervical cancer, and to further explore the association with the expression level and the clinical stage and prognosis of cervical cancer. According to the analysis of training set, we identified 29 IRGPs as key gene pairs and constructed the model. The AUC value of the model was greater than 0.9, and the model group survival rate was conspicuous different (P < 0.001). The reliability of the model was confirmed in the validation group. Our IRGPs play an important role in the occurrence and development of cervical cancer, and can be used as a prognostic marker and potential new target of cervical cancer.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Reference56 articles.

1. Stewart Bernard, W. et al. Cancer prevention as part of precision medicine: “plenty to be done”. Carcinogenesis 37(1), 2–9. https://doi.org/10.1093/carcin/bgv166 (2016).

2. Bray, F. et al. Global cancer statistics 2018: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68, 394–424. https://doi.org/10.3322/caac.21492 (2018).

3. Passos Camila, M., Sales Jacqueline, B., Maia Emanuella, G., Caldeira Thaís, C M., Rodrigues Roberta, D., Figueiredo N., Claro Rafael M. (2020). Trends in access to female cancer screening in Brazil, 2007–16. J Public Health (Oxf), https://doi.org/10.1093/pubmed/fdaa028

4. Asrabuddhe, V. V., Parham, G. P., Mwanahamuntu, M. H. & Vermund, S. H. Cervical cancer prevention in low- and middle-income countries: feasible, affordable, essential. Cancer Prevent. Res. 5, 11–17. https://doi.org/10.1158/1940-6207.CAPR-11-0540 (2012).

5. Koh Wui-Jin., Abu-Rustum Nadeem R., Bean Sarah., Bradley Kristin., Campos Susana M., Cho Kathleen R., Chon Hye Sook., Chu Christina., Clark Rachel., Cohn David., Crispens Marta Ann., Damast Shari., Dorigo Oliver., Eifel Patricia J., Fisher Christine M., Frederick Peter., Gaffney David K., Han Ernest., Huh Warner K., Lurain John R., Mariani Andrea., Mutch David., Nagel Christa., Nekhlyudov Larissa., Fader Amanda Nickles., Remmenga Steven W., Reynolds R Kevin., Tillmanns Todd., Ueda Stefanie., Wyse Emily., Yashar Catheryn M., McMillian Nicole R., Scavone Jillian L.(2019). Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology. J. Natl. Compr. Canc Netw., 17(1), 64–84. https://doi.org/10.6004/jnccn.2019.0001

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3